CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma

Glioblastoma (GBM) is a lethal brain tumour. Despite therapy with surgery, radiation, and alkylating chemotherapy, most people have recurrence within 6 months and die within 2 years. A major reason for recurrence is resistance to DNA damage. Here, we demonstrate that CHD4, an ATPase and member of th...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Rep
Auteurs principaux: McKenzie, Lisa D., LeClair, John W., Miller, Kayla N., Strong, Averey D., Chan, Hilda L., Oates, Edward L., Ligon, Keith L., Brennan, Cameron W., Chheda, Milan G.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6418088/
https://ncbi.nlm.nih.gov/pubmed/30872624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-40327-w
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires